Freya Meds is a fully online, medically guided weight-loss program that connects you with licensed doctors who can prescribe GLP-1 medications such as semaglutide or tirzepatide. You start by completing a short online health assessment, after which a licensed clinician reviews your medical history and goals to determine eligibility. If approved, your personalized treatment plan is created and medication is shipped directly to your home, with ongoing medical support throughout your journey.

Freya Meds is designed for adults who want medically supervised weight loss. Eligibility is determined by a licensed healthcare provider who reviews your health history, current medications, weight-loss goals, and overall medical profile. Not everyone qualifies, and prescriptions are only provided when the clinician determines that GLP-1 treatment is appropriate and safe.

Freya Meds offers two primary GLP-1-based treatment options:

• Semaglutide – a medication that mimics the natural GLP-1 hormone to reduce appetite and help you feel full longer.

• Tirzepatide – a dual-action medication that supports appetite control and metabolic balance.

Both treatments are prescribed based on your health profile and may be combined with guidance on nutrition, lifestyle changes, and progress tracking.

Weight-loss results vary depending on your body, lifestyle, and adherence to the program. Many patients begin noticing changes within the first few weeks as GLP-1 medications help reduce appetite and calorie intake. On average, some users report losing around 9 pounds in the first month, though results differ from person to person and are monitored by your doctor to ensure safe progress.

Freya Meds offers transparent monthly pricing that includes medication, consultations, and shipping. Typical plans include:

• Semaglutide: about $250 per month (or lower with annual plans)

• Tirzepatide: about $332 per month

The price usually includes medication, syringes, shipping, and access to medical consultations and support.

No. Freya Meds does not require insurance. The program is designed as a direct-to-consumer telehealth service with transparent pricing, allowing patients to pay monthly without relying on insurance coverage or long-term contracts.

Yes, in many cases. If you’ve been prescribed semaglutide or tirzepatide by another provider, your Freya Meds clinician will take that into account when determining your starting dose. Simply note your current or most recent dose on your intake form — your clinician will review it and confirm the right starting point for your treatment.

All medications are prescribed as a monthly supply, and your specific vial size and concentration are determined by your personalized dosing protocol — established by your clinician based on your health profile, treatment history, and goals. Protocols typically include gradual dose increases each month as your body adjusts to the medication, and those increases are built into your program at no extra cost. If you’re currently receiving treatment elsewhere or have recently done so, make sure to include your current or most recent dose on your intake form so your provider can factor that in from day one.

Your payment covers your full monthly treatment plan, not a specific vial — so regardless of what dose your clinician determines is right for you, the cost stays the same. Most patients progress through gradual dose increases each month as part of their protocol, and those are included in your plan at no extra cost. Think of it like a monthly membership: your clinician reviews your intake form and assigns your personalized starting dose as part of onboarding. If you’ve recently been on semaglutide or tirzepatide elsewhere, note your previous dose on your intake form and your provider will align with where you left off.